Intravenously Administered Anti-recoverin Antibody Alone Does Not Pass through the Blood-Retinal BarrierIntravenously Administered Anti-recoverin Antibody Alone Does Not Pass through the Blood-Retinal Barrier
- Other Titles
- Intravenously Administered Anti-recoverin Antibody Alone Does Not Pass through the Blood-Retinal Barrier
- Authors
- 김정훈; 김진형; 김동훈; 박웅양; 김규원; 유영석
- Issue Date
- 2011
- Publisher
- 대한안과학회
- Keywords
- Anti-recoverin antibody; Blood-retinal barrier; Cancer-associated retinopathy; Intravenous administration; Retina
- Citation
- Korean Journal of Ophthalmology, v.25, no.3, pp 189 - 195
- Pages
- 7
- Journal Title
- Korean Journal of Ophthalmology
- Volume
- 25
- Number
- 3
- Start Page
- 189
- End Page
- 195
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/19777
- ISSN
- 1011-8942
2092-9382
- Abstract
- Purpose: Cancer-associated retinopathy is a paraneoplastic retinal degeneration which may primarily result from auto-immune mediated apoptosis. It has been hypothesized that high titer of auto-antibodies are able to cross the blood-retinal barrier (BRB) and to enter retinal cells to activate apoptotic pathway which has been already well-established. However, it still remains to be elucidated whether auto-antibodies could cross BRB in the retina.
Herein, we demonstrated that intravenously administrated anti-recoverin antibodies could not pass through BRB and not lead to retinal cell death.
Methods: Anti-recoverin antibody was intravenously injected to C57BL/6 mice, which were sacrificed 1 and 7 days to obtain eye. Vascular endothelial growth factor was intravitreally injected to induce BRB breakdown, which was confirmed by fluorescein angiography and western blotting for zonula occludens (ZO)-1, ZO-2 and occludin. To investigate the location of anti-recoverin antibody in the retina, immunofluorescein was performed. The retinal toxicity of intravenous anti-recoverin antibody was evaluated by histological examination and transferase-mediated dUTP nick-end labeling. Immunofluorescein staining for glial fibrillary acidic protein was done to address glial activation as well.
Results: Intravenously administrated anti-recoverin antibodies were exclusively distributed on retinal vessels which were co-localized with CD31, and led to neither increase of glial fibrillary acidic protein expression, as an indicator of retinal stress, nor apoptotic retinal cell death. Moreover, even in the condition of vascular endothelial growth factor-induced BRB breakdown, anti-recoverin antibodies could not migrate across BRB and still remained on retinal vessels without retinal cytotoxicity.
Conclusions: Our results suggest that high titer of intravascular anti-recoverin antibodies could not penetrate into the retina by themselves, and BRB breakdown mediated by dysregulation of tight junction might not be sufficient to allow anti-recoverin antibodies to pass through BRB.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Radiology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.